Workflow
ADI/Adimune
icon
Search documents
Aditx Therapeutics(ADTX) - Prospectus(update)
2024-06-05 20:23
As filed with the Securities and Exchange Commission June 5, 2024 Registration Statement No. 333-276588 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 4 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ADITXT, INC. (Exact name of registrant as specified in its charter) (Primary Standard Industrial Delaware 23219 82-3204328 (I.R.S. Employer Identification Number) Classification Code Number) 2569 Wyandotte St., Suite 101 Mountainview, CA 94043 (650) 87 ...